ストックスクリーナーアプリを入手
100.70
3.13%
-3.25
プレマーケット:
102.21
1.51
+1.50%
前日終値:
$103.95
開ける：
$104.16
24時間の取引高:
724.16K
Relative Volume:
1.28
時価総額：
$4.63B
収益：
$354.54M
当期純損益:
$23.65M
株価収益率:
217.64
EPS:
0.4627
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.65%
1か月 パフォーマンス:
+21.87%
6か月 パフォーマンス:
+9.50%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$99.14
$105.38
1週間の範囲:
$96.76
$105.38
52週間の値動き範囲:
$61.96
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Compare BLLN vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
100.70 | 4.78B | 354.54M | 23.65M | 0 | 0.4627 |
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-06 | 開始されました | Guggenheim | Buy |
| 2025-12-01 | 開始されました | BTIG Research | Buy |
| 2025-12-01 | 開始されました | JP Morgan | Overweight |
| 2025-12-01 | 開始されました | Jefferies | Hold |
| 2025-12-01 | 開始されました | Piper Sandler | Overweight |
| 2025-12-01 | 開始されました | Stifel | Buy |
| 2025-12-01 | 開始されました | Wells Fargo | Equal Weight |
| 2025-12-01 | 開始されました | William Blair | Outperform |
すべてを表示
Billiontoone Inc (BLLN) 最新ニュース
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
BillionToOne (BLLN) director awarded 3,017 RSUs of Class A stock - Stock Titan
BillionToOne (BLLN) director and 10% owner awarded 3,017 RSUs in stock grant - Stock Titan
BillionToOne (BLLN) director and 10% owner receives 3,017 RSU equity award - Stock Titan
BillionToOne (BLLN) awards 3,017 RSUs to board director Pagano - Stock Titan
BillionToOne (BLLN) director granted 3,017 RSUs with service-based vesting - Stock Titan
Top Billiontoone (BLLN) Competitors 2026 - MarketBeat
BillionToOne (NASDAQ: BLLN) director logs 481,807-share in-kind restructuring across Neotribe funds - Stock Titan
BillionToOne (BLLN) NeoTribe funds move 465,607 shares in restructuring - Stock Titan
BillionToOne(BLLN.US) Officer Sells US$3.79 Million in Common Stock - Moomoo
Nancy Johnson Sells 14,000 Shares of BillionToOne Inc (BLLN) - GuruFocus
BillionToOne CPO Sakakibara sells $785,800 in company stock By Investing.com - Investing.com India
BillionToOne SVP Nancy Johnson sells $1.4m in stock By Investing.com - Investing.com Nigeria
BillionToOne CEO Atay Oguzhan sells $3.79m in stock By Investing.com - Investing.com Australia
BillionToOne CPO Sakakibara sells $785,800 in company stock - Investing.com
BillionToOne SVP Nancy Johnson sells $1.4m in stock - Investing.com
BillionToOne CEO Atay Oguzhan sells $3.79m in stock - Investing.com
BillionToOne (NASDAQ: BLLN) officer sells 14,000 shares under 10b5-1 plan - Stock Titan
BillionToOne (BLLN) CPO sells 8,000 shares under Rule 10b5-1 plan - Stock Titan
3 Stocks Conceivably Trading At Discounts Of Up To 49.6% - simplywall.st
BLLN (NASDAQ) Form 144: Insider resale, 3,418 shares sold reported - Stock Titan
[144] BillionToOne, Inc. SEC Filing - Stock Titan
How Investors May Respond To BillionToOne (BLLN) Conference Spotlight And Apparent Discount To Intrinsic Value - simplywall.st
Earnings call transcript: BillionToOne’s Q1 2026 revenue surges 84% YoY - Investing.com
BillionToOne Q1 2026 slides: 84% revenue surge, 73% gross margin - Investing.com
BillionToOne set to report earnings amid product expansion push By Investing.com - Investing.com Nigeria
BLLN Technical Analysis | Trend, Signals & Chart Patterns | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill
Billiontoone (BLLN) Stock Trends and Sentiment 2026 $BLLN - MarketBeat
Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
BillionToOne Inc. (BLLN) Surges 7.45%: Key Levels and Potential Drivers Behind the RallyVolatility Skew - thelegaladvocate.com
BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference - Moomoo
3 Promising Growth Companies With Insider Ownership Up To 27% - Sahm
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect? - Zacks Investment Research
Transcript : BillionToOne, Inc., Q1 2026 Earnings Call, May 06, 2026 - marketscreener.com
BillionToOneStarting 2026 Strong (NASDAQ:BLLN) - Seeking Alpha
Jim Cramer on BillionToOne: “I Say Buy It” - Insider Monkey
BillionToOne Launches Non-Invasive Prenatal Confirmation Test Using Fetal Cells - Clinical Lab Products
BillionToOne's (NASDAQ:BLLN) Strong Earnings Are Of Good Quality - 富途牛牛
Cramer: Design Therapeutics Is ‘Pure Spec,’ Buy This Health Care StockBillionToOne (NASDAQ:BLLN), Desi - Benzinga
Cramer's lightning round: Buy BillionToOne - MSN
Billiontoone Inc (BLLN) 財務データ
収益
当期純利益
現金流量
EPS
0.56%
0.44%
大文字化:
|
ボリューム (24 時間):